Development and validation of a nomogram for predicting the overall survival of patients with testicular cancer

• الحاوية / القاعدة: Cancer Medicine
• المؤلفون الرئيسيون: Haohui Yu, Bin Feng, Yunrui Zhang, Jun Lyu
• التنسيق: مقال
• اللغة: الإنجليزية
• منشور في: Wiley 2023-07-01
• الموضوعات: nomogram; overall survival; SEER; testicular cancer
• الوصول للمادة أونلاين: https://doi.org/10.1002/cam4.6203

Abstract Background The purpose of this study was to develop and validate a nomogram to predict survival in testicular cancer patients. Methods Testicular cancer patients diagnosed between 2004 and 2015 from the Surveillance, Epidemiology, and End Results (SEER) database were selected for this study. A random sampling method was used to divide patients into training and validation cohorts, which accounted for 30% and 70% of the total sample, respectively. The nomogram was developed using the training cohort and evaluated using the C index, calibration chart, and area under the receiver operating characteristic curve (AUC). Results Seven risk factors that affect the survival of testicular cancer patients (AJCC stage, marital status, age at diagnosis, race, SEER historic stage A, surgery status, and origin) were identified using Cox proportional hazard regression analysis. The nomogram has a higher C index (0.897) and AUC when compared with the AJCC staging system. The results of the calibration chart of the nomogram show that the predicted survival of testicular cancer patients at 3, 5, and 10 years after diagnosis is very close to their actual survival. Conclusions We developed and validated a nomogram for predicting the survival rate of testicular cancer patients at 3, 5, and 10 years after diagnosis. This nomogram has better discrimination, calibration, and clinical validity than the AJCC staging system. This indicates that the nomogram can be used to predict the survival of testicular cancer patients effectively, and provide a reference for patient treatment strategies.